Détail de l'auteur
Documents disponibles écrits par cet auteur (5)
Ajouter le résultat à ma sélection Faire une suggestion Affiner la recherche
Article
M.E. HALLORAN ; Imjr LONGINI ; Arnold-S MONTO, éd. ; C.J. STRUCHINER ; Stephen-B THACKER, éd. ; Department of Biostatistics. Rollins School of Public Health. Emory University. Atlanta. GA. USA |[BDSP. Notice produite par INIST 3R0xmcLh. Diffusion soumise à autorisation].
Article
L.K. DURHAM ; J.D. CLEMENS ; M.E. HALLORAN ; Imjr LONGINI ; A. NIZAM ; M. RAO ; Department of Biostatistics. The Rollins School of Public Health. Emory University. Atlanta GA. USA ; Division of Epidemiology. Statistics. And Prevention. National Institute of Child Health and Human Development. National Institutes of Heath. Bethesda MD. USA |[BDSP. Notice produite par INIST lR0xBS7I. Diffusion soumise à autorisation]. The authors present a nonparametric method for estimating vaccine efficacy as a smooth function of time from vaccine trials. Use of the method requires a minimum of as[...]
Article
M.E. HALLORAN ; Imjr LONGINI ; C.J. STRUCHINER ; Department of Biostatistics. Rollins School of Public Health. Emory University. Atlanta GA. USA |[BDSP. Notice produite par INIST Bc7R0xXd. Diffusion soumise à autorisation]. Vaccine efficacy and effectiveness (VE) are generally measured as 1 minus some measure of relative risk (RR) in the vaccinated group compared with the unvaccinated gro[...]
Article
M.E. HALLORAN ; Imjr LONGINI ; C.J. STRUCHINER ; Department of Biostatistics. Rollins School of Public Health. Emory University. Atlanta GA. USA |[BDSP. Notice produite par INIST vR0x7Jq2. Diffusion soumise à autorisation]. The authors consider estimability and interpretation of vaccine efficacy based on time to event data, allowing that some of the population might have a very low probab[...]
Article
M. HABER ; M.E. HALLORAN ; Imjr LONGINI ; W.A. ORENSTEIN ; Emory univ. Rollins school public health. Dep biostatistics. Atlanta GA. USA |[BDSP. Notice produite par INIST iR0xkiSS. Diffusion soumise à autorisation]. A common source of bias in evaluating vaccine efficacy following a disease outbreak is the presence of persons who had the disease prior to the outbreak. This paper ex[...]
